Evidence map›Paper›PMID 31052337›Full record

ReviewGenes2019

Post-Translational Modifications of the Mini-Chromosome Maintenance Proteins in DNA Replication.

Zheng Li, Xingzhi Xu

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. CDC7 and APC/CNature communications · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zheng LiGuangdong Key Laboratory for Genome Stability & Disease Control and Carson International Cancer Center, Shenzhen University School of Medicine, Shenzhen 518060, Guangdong, China. buctlz@hotmail.com.
Xingzhi XuGuangdong Key Laboratory for Genome Stability & Disease Control and Carson International Cancer Center, Shenzhen University School of Medicine, Shenzhen 518060, Guangdong, China. Xingzhi.Xu@szu.edu.cn.
Shenzhen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The eukaryotic mini-chromosome maintenance (MCM) complex, composed of MCM proteins 2-7, is the core component of the replisome that acts as the DNA replicative helicase to unwind duplex DNA and initiate DNA replication. MCM10 tightly binds the cell division control protein 45 homolog (CDC45)/MCM2-7/ DNA replication complex Go-Ichi-Ni-San (GINS) (CMG) complex that stimulates CMG helicase activity. The MCM8-MCM9 complex may have a non-essential role in activating the pre-replicative complex in the gap 1 (G1) phase by recruiting cell division cycle 6 (CDC6) to the origin recognition complex (ORC). Each MCM subunit has a distinct function achieved by differential post-translational modifications (PTMs) in both DNA replication process and response to replication stress. Such PTMs include phosphorylation, ubiquitination, small ubiquitin-like modifier (SUMO)ylation,

Indexed as

Cell Cycle ProteinsCell NucleusChromosomesDNA ReplicationG1 PhaseGenomic InstabilityHumansMinichromosome Maintenance ProteinsOrigin Recognition ComplexProtein Processing, Post-TranslationalCDC45 protein, humanCell Cycle ProteinsMinichromosome Maintenance ProteinsOrigin Recognition Complexcancercell cyclediseaseDNA replicationgenome stabilitymini-chromosome maintenance (MCM)post-translational modifications (PTMs)

Identifiers

PMID31052337
PMCPMC6563057
OpenAlexW2942957973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.